GGrantIndex
Sort

40,608 grants matching prostate cancer

Illinois Oncology Research Association Community Clinical Oncology Program

$812,293
Nguyet A. Le-Lindqwister · Oncology-Hematology Assoc-Central Ill · U10 · FY2012 · CA

Novel Isotopic Spectroscopy Imaging Tools for Advancing Targeted Alpha Cancer Therapies

$811,877
Jared William Moore · Qscint Imaging Solutions, Llc · R44 · FY2025 · EB

A Deep Learning Model to Improve Pathologist Interpretation of Donor Kidney Biopsies

$811,695
Joseph P Gaut · Newventureiq, Llc · R42 · FY2020 · DK

Genetic Epidemiology of Cancer

$811,554
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2012 · HG

Novel Isotopic Spectroscopy Imaging Tools for Advancing Targeted Alpha Cancer Therapies

$811,503
Jared William Moore · Qscint Imaging Solutions, Llc · R44 · FY2024 · EB

A Targeted Decision Aid to Improve Minority Participation in Clinical Trials

$811,366
Margaret M Byrne · University Of Miami School Of Medicine · RC2 · FY2010 · MD

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer

$811,268
Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2021 · CA

RADIOGENOMIC CHARACTERIZATION OF PROSTATE CANCER: DISTINGUISHING AGGRESSIVE FROM INDOLENT DISEASE

$811,200
Regents Of The University Of Michigan · · FY2018 · Defense Health Agency

THE THOC1 RIBONUCLEOPROTEIN AS A NOVEL BIOMARKER FOR PROSTATE CANCER TREATMENT ASSIGNMENT

$811,040
Health Research, Inc. · · FY2014 · Department of Defense

National Capital Area (NCA) Minority/Underserved NCORP

$810,991
Lucile L Adams-Campbell · Georgetown University · UG1 · FY2024 · CA

MOLECULAR APPROACHES TO DISCOVER MARINE NATURAL PRODUCT

$810,862
University Of California Santa Cruz · U19 · FY2003 · CA

Mechanism of epigenetic activation during disease progression

$810,824
David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Identification of epigenetic drivers of advanced prostate cancer

$810,824
David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

CLINICAL NUTRITION RESEARCH UNIT

$810,667
University Of California Los Angeles · P01 · FY2001 · CA

Enhancing ARIC Infrastructure to Yield a New Cancer Epidemiology Cohort

$810,571
Elizabeth A. Platz · Johns Hopkins University · U01 · FY2016 · CA

System for Automatic Segmentation of Male Pelvis Structures from CT Images

$810,402
Edward L. Chaney · Morphormics, Inc. · R44 · FY2010 · CA

Vaccine and radiation for the therapy of human cancers

$810,351
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Vaccine and Drug Combination Therapy for Human Cancers

$810,351
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry

$810,157
Kenneth J. Pienta · Johns Hopkins University · U01 · FY2016 · CA

NEW COMBINATION THERAPIES FOR ADVANCED PROSTATE CANCER BASED ON THE RADIOSENSITIZING POTENTIAL OF 5-AZACYTIDINE

$810,000
University Of Arizona · · FY2011 · Department of the Army

Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry

$809,998
Kenneth J. Pienta · Johns Hopkins University · U01 · FY2015 · CA

Investigating the Roles of Patient Beliefs, Stigma, and Physician Implicit Bias on Disparities in Lung Cancer Screening

$809,758
Minal S Kale · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · MD

Center for Applied Preclinical Research (CAPR)

$809,748
Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Molecular Orgin Cancer--Catechol Estrogen 3 4 Quinones

$809,714
University Of Nebraska Medical Center · P01 · FY2003 · CA

Project 3 - INSM1, A Candidate Therapeutic Target in High-Grade Neuroendocrine Carcinomas

$809,684
James A Decaprio · Dana-Farber Cancer Inst · P01 · FY2025 · CA